This test is most useful if any of these apply to you.
Lead is one of the few metals with no known biological role and no safe level of exposure. A 24-hour urine collection captures every drop of urine you produce over a full day, then measures the total amount of lead your kidneys removed from your blood in that window. That total gives you a snapshot of how much lead your body is actively clearing, which reflects what you have been exposed to recently or what your body is mobilizing from storage.
This test is most often ordered in occupational or medical settings, but it can also be useful if you suspect an ongoing exposure at home, from old paint, imported ceramics, contaminated water, or hobbies involving soldering, ammunition, or stained glass. It works best as part of a picture that also includes a blood lead level, not as a standalone number.
The lab quantifies the mass of elemental lead excreted in your urine over exactly 24 hours. Because urine lead reflects what the kidneys have cleared recently, it changes more rapidly than blood lead, which itself has a half-life of about 35 days. Lead stored in bone can persist for years to decades. That means a 24-hour urine result tells you more about recent excretion and mobilizable lead than about your long-term body burden.
Two versions of this test exist. The routine, unprovoked collection measures baseline daily excretion. The provoked or mobilization version measures excretion after you receive a chelating drug (a medication designed to bind heavy metals and pull them out of tissues), which shifts stored lead into a form your kidneys can dump. Both use the same 24-hour collection format, but they answer different questions and are interpreted differently.
Across the research, whole-blood lead is the biomarker that best distinguishes people with different average lead exposure. One large biomonitoring study concluded that urine lead should not be used as the primary marker of lead exposure, and another found that at low exposure levels, urine lead cannot reliably predict blood lead concentrations. The relationship between urine and blood lead is real but weakens sharply at lower blood lead concentrations.
That said, a well-collected 24-hour urine lead sample correlates fairly strongly with blood lead in healthy adults, with a correlation of about 0.77 (a number close to 1.0 would mean the two values move almost perfectly together). Once you adjust the urine for how dilute it is, the reproducibility from day to day is fairly good, with a measure of consistency between roughly 0.75 and 0.90 in stable non-smokers. So the test is useful, but it is a supporting player rather than the star.
A high 24-hour urine lead suggests one of three things: you have had recent or ongoing exposure, your body is mobilizing lead out of stored sites (which happens naturally with bone turnover, pregnancy, breastfeeding, or aggressive weight loss), or you have been given a chelating drug. Interpreting a high number requires knowing which of these applies.
A low 24-hour urine lead usually means little measurable excretion, which is expected in most people without recent exposure. On its own, a low value is reassuring, but it does not rule out chronic body burden stored in bone. Someone with substantial old lead exposure from childhood or a former occupation can have low urinary excretion today while still carrying decades of accumulated lead in their skeleton, which is why bone lead measurement or provoked testing is sometimes used in high-suspicion cases.
Lead damages blood vessels and the heart at levels once considered safe. In a US analysis of 14,305 adults, higher urinary lead was associated with about 18% higher risk of cardiovascular death in models that accounted for competing causes. In a separate group of 6,453 adults with high blood pressure, people in the highest quarter of blood lead had roughly 73% higher risk of dying from any cause compared with those in the lowest quarter, and each unit increase in blood lead was linked to about 23% higher mortality risk.
A landmark analysis of 14,289 US adults followed for a median of 19.3 years found that going from a blood lead near the tenth percentile to the ninetieth percentile was associated with about 37% higher all-cause mortality, 70% higher cardiovascular mortality, and roughly twice the risk of dying from ischemic heart disease. Urine and blood lead were also linked to arterial stiffness in lead-exposed workers, an early sign of vascular aging.
Lead is directly toxic to the tubules of the kidney, and the kidneys are also the exit route for most excreted lead. In a US cohort of 2,320 adults with chronic kidney disease followed for a median of about 6.5 years, people in the highest quarter of urinary lead had roughly 77% higher risk of dying from any cause compared with those in the lowest quarter. Each unit increase in urine lead was associated with about 21% higher mortality, an association that held after adjustment for age, lifestyle, and other conditions.
In occupationally exposed workers, urinary KIM-1 (a marker released when kidney tubules are injured) correlated better with blood lead than older kidney markers, suggesting that lead can produce measurable kidney stress even before standard tests move. A separate randomized trial in people with chronic kidney disease and a high-normal lead burden found that weekly chelation over 27 months improved kidney filtration by 2.1 mL/min/1.73 m², while the untreated group lost 6.0 mL/min/1.73 m² over the same period.
Beyond kidneys and heart, lead impairs the enzyme your body uses to build hemoglobin, the oxygen-carrying protein in red blood cells. This is why urinary aminolevulinic acid (ALA), a chemical that piles up when this enzyme is blocked, has long been used as a marker of early lead effect. Chronic lead exposure has been linked to anemia, peripheral nerve dysfunction, cognitive decline in adults, and irreversible neurodevelopmental harm in fetuses and children. Urine lead is not the sharpest tool for these outcomes in isolation, but a high value should prompt broader evaluation.
A systematic review of lead in blood and urine found that higher lead levels are consistently associated with higher overall cancer incidence and mortality, particularly cancers of the gastrointestinal tract and the bladder and urinary tract. Inorganic lead compounds are classified by the International Agency for Research on Cancer as probable human carcinogens (Group 2A), while lead metal itself is classified as possibly carcinogenic to humans (Group 2B). The biology behind the cancer link is not as well mapped as lead's effects on the heart and kidneys.
Urine lead behaves differently over different time windows. Day-to-day reproducibility in stable healthy adults is decent, with consistency scores between 0.75 and 0.90. But over three months, urine lead can vary substantially in the same person, with reproducibility scores between 0.01 and 0.29 in one study of healthy men. A single 24-hour collection reflects the day it was taken. It does not reliably represent your average exposure over weeks or months.
For proactive tracking, get a baseline, then repeat in 3 to 6 months if you are making changes (removing an exposure source, doing renovation cleanup, changing water filtration). If you are being monitored during or after chelation, retest on the schedule your clinician recommends, which is usually more frequent. If your baseline is low and your exposures have not changed, at least annual monitoring is reasonable if you have known risk factors, and every 2 to 3 years otherwise. Pair urine lead with a blood lead level whenever possible, since the two together give a much clearer picture than either alone.
The most common cause of a misleading result is an incomplete collection. If you forget a void, spill a portion, or start the 24-hour clock at the wrong time, the total lead will be systematically low. Because 24-hour excreted mass depends on capturing every drop of urine over exactly 24 hours, technique matters more here than for a routine blood test.
If you have received a chelating drug like EDTA or DMSA (succimer) before the 24-hour collection, the test is called a mobilization or provoked test. This version measures how much lead your kidneys can pull out when a drug is dragging it out of soft tissues and some bone. Provoked urine lead peaks within 2 to 3 hours of oral DMSA and about 6 hours after intravenous EDTA. With DMSA specifically, the excretion typically climbs 5- to 20-fold above baseline during a 5-day course. Head-to-head comparisons suggest EDTA produces roughly threefold higher urinary lead than DMSA, because the two drugs reach different lead storage pools.
Provoked testing has real diagnostic value, especially in occupational medicine and in evaluating chronic exposure, but its clinical usefulness is strongest when blood lead is already substantially elevated. In the general public, most experts do not recommend provoked testing as a routine screen. The drug itself has side effects, the interpretation depends on the drug and dose, and there are simpler ways to detect current exposure.
An unexplained high 24-hour urine lead should trigger a workup, not a wait. Get a blood lead level, since the two together tell you whether the exposure is recent (blood lead rises) or a chronic body burden mobilizing out (blood lead may be lower than expected). Ask for a complete blood count with red cell indices to check for anemia, a basic metabolic panel to assess kidney function, and if kidney concern is high, urine albumin and a cystatin C-based estimate of filtration rate. If you have known occupational exposure, an occupational medicine specialist should be involved. If the exposure source is unclear, an environmental health assessment of your home, hobbies, and water supply is the next step.
For borderline results, a repeat 24-hour collection under standardized conditions is more useful than jumping to intervention. The goal is to distinguish a genuine ongoing exposure from a testing artifact or brief mobilization event.
In healthy adults, men excrete more lead in urine over 24 hours than women. In one population study, average excretion was 64 nmol per 24 hours in adult men versus 40 nmol per 24 hours in women, a difference of about 60%. Urinary lead output also rises with age until roughly 50, reflecting decades of accumulated exposure being slowly released. Rural residents can have higher urinary lead than urban residents in some regions, depending on soil, water, and occupational patterns. Interpret your number in the context of who you are, not against a single fixed number.
Evidence-backed interventions that affect your Lead level
Lead is best interpreted alongside these tests.
Lead is included in these pre-built panels.